Product Images Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol NDC 0378-7284 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure - 50bc7836 dbb6 439f 83b3 88f1f8758fc5 01

Figure - 50bc7836 dbb6 439f 83b3 88f1f8758fc5 01

Structure - 50bc7836 dbb6 439f 83b3 88f1f8758fc5 02

Structure - 50bc7836 dbb6 439f 83b3 88f1f8758fc5 02

Levonorgestrel is a chemical compound with the molecular formula C21H28O2 and a molecular weight of 312.4 g/mol.*

Structure - 50bc7836 dbb6 439f 83b3 88f1f8758fc5 03

Structure - 50bc7836 dbb6 439f 83b3 88f1f8758fc5 03

Ethinyl Estradiol is a chemical compound with a molecular weight (MW) of 296.4. No other information is available from the provided text.*

Levonorgestrel and Ethinyl Estradiol Tablets, USP (0.1 mg/ 0.02 mg) and Ethinyl Estradiol Tablets, USP (0.01 mg) Carton Label - image 01

Levonorgestrel and Ethinyl Estradiol Tablets, USP (0.1 mg/ 0.02 mg) and Ethinyl Estradiol Tablets, USP (0.01 mg) Carton Label - image 01

This is a description of a contraceptive pill package with the NDC 0378-7284-90, containing a total of 182 tablets (91 tablets per pouch) to be taken daily for 91 consecutive days. The package also includes patient instructions, but it should be noted that this product, like all oral contraceptives, is intended to prevent pregnancy only and does not protect against HIV or other sexually transmitted diseases. The package is manufactured by Mylan Pharmaceuticals Inc. and must be stored at a controlled room temperature between 20°C and 25°C.*

Image - image 02

Image - image 02

This appears to be a list of various birth control methods available, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal rings with hormones, condoms, diaphragm, spermicide, withdrawal, and no sex during the most fertile days of the monthly cycle. The text also makes a comparison between the effectiveness of different methods in preventing pregnancy, with some methods being more reliable than others.*

Blister - image 03

Blister - image 03

This is a label of Levonorgestrel and Ethinyl Estradiol Tablets with USP, (0.1 mg/0.02 mg) and Ethinyl Estradiol Tablets USP, (0.01 mg) with details of manufacturing location, lot number, and expiry date. Store the tablets at 20° to 25°C (68° to 77°F). The label has an NDC code, but apart from that, no other useful information is available from the given text.*

image 04

image 04

This text provides a list of studies and their corresponding effect estimates related to the use of combined oral contraceptives (COC). The studies compare the risk of certain outcomes between individuals who have ever used COC and those who have never used COC, as well as between individuals who are currently using COC and those who have never used COC. The outcomes and risk ratios (OR, RR, HR) are presented in parentheses.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.